AGP Executive Report
Last update: 2 hours agoEmerging Infection: Health officials are investigating the first confirmed human Shamonda virus infection, in an immunocompromised older man in France who died after developing encephalitis. The source is unclear, and experts say one case does not show a wider risk to the public. Medicine Safety: The European Medicines Agency is reviewing Deanxit after reports of movement disorders and memory problems, some of which reportedly continued after treatment stopped. Cancer Care: The first European patients have received ImmunityBio’s bladder cancer treatment Anktiva with BCG in Germany and Austria; its conditional European approval also covers Liechtenstein. Health Cover: Liechtenstein-based insurer Squarelife is backing Genki Native’s expanded international health plan, which now offers cover from one month and adds preventive and dental care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.